Kane Biotech

Kane Biotech Assets per Share

The Total Assets per Share of Kane Biotech (KNE.V) as of Oct 17, 2026 is 0.02 CAD. In the previous year, Total Assets per Share was 0.01 CAD — a change of 9.62% (higher).

Assets per Share

0.02CAD

YoY

9.62%

Last updated:

Total Assets per Share of Kane Biotech is 2025 0.02 CAD. Total Assets per Share of Kane Biotech was 2024 0.01 CAD. It decreases by 9.62% higher compared to the previous year.

The Kane Biotech Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.01 CAD
Jan 1, 2019
0.02 CAD
Jan 1, 2020
0.03 CAD
Jan 1, 2021
0.03 CAD
Jan 1, 2022
0.03 CAD
Jan 1, 2023
0.03 CAD
Jan 1, 2024
0.01 CAD
Jan 1, 2025
0.02 CAD
The Kane Biotech Assets per Share history
YEARAssets per ShareYoY
0.02CAD+9.62%
0.01CAD-56.10%
0.03CAD+1.09%
0.03CAD-8.39%
0.03CAD+21.82%
0.03CAD+82.74%
0.02CAD+77.11%
0.01CAD-54.20%
0.02CAD+59.40%
0.01CAD+81.67%
0.01CAD-41.03%
0.01CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kane Biotech Stock analysis

What does Kane Biotech do? Kane Biotech Inc is a biotechnology company based in Winnipeg, Manitoba, Canada. The company went public on May 7, 2003, with its stock ticker KNE.V and ISIN CA4838092084. Kane Biotech focuses on researching, developing, and commercializing technologies and products designed to prevent and remove microbial biofilms. The company's product portfolio includes StrixNB, DispersinB, Aledex, bluestem (available in water additives, chews, spray, and dental wipes), silkstem, goldstem, coactiv+, and DermaKB Biofilm. Its Wound Care & Surgical division is developing DispersinB for chronic wound care applications. The company also offers products such as Scalp Detoxifier, Shampoo, and Shampoo Bars. Kane Biotech's primary market focus is on animal health, though it also develops products for human wound care and surgical applications. The company's product development includes Coactiv+ as an antimicrobial wound rinse and surgical hydrogel, as well as DispersinB Gel for prosthetic joint infections. Kane Biotech operates within the Health Care sector, specifically in the Biotechnology industry. The company's website is https://kanebiotech.com/ and it is headquartered in Winnipeg, Canada. Kane Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kane Biotech stock

Total Assets per Share of Kane Biotech is 0.02 CAD in 2025.

Total Assets per Share of Kane Biotech changed from 0.01 CAD to 0.02 CAD, representing a 9.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Kane Biotech since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Other — Kane Biotech

Shares OutstandingSupply ChainNet Debt per ShareAssets per Share

All Key Metrics — Kane Biotech